Crossref
Pharmacoeconomics of Three Hepatoprotectives for Liver Injury Induced by Antituberculosis Therapy
West Indian Medical Journal · 2017
DOI: 10.7727/wimj.2017.016 ↗Kurz gefasst
Fachartikel in der Zeitschrift West Indian Medical Journal, 2017. Verfasst von C Yu und 7 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Yu, C., Peng, Y., Chongwu, R., Pengfei, R., Zheng, M., Lin, Z., Wenliang, Z., & Changjie, J. (2017). Pharmacoeconomics of Three Hepatoprotectives for Liver Injury Induced by Antituberculosis Therapy. West Indian Medical Journal. https://doi.org/10.7727/wimj.2017.016
Vancouver
Yu C, Peng Y, Chongwu R, Pengfei R, Zheng M, Lin Z, et al. Pharmacoeconomics of Three Hepatoprotectives for Liver Injury Induced by Antituberculosis Therapy. West Indian Medical Journal. 2017. doi:10.7727/wimj.2017.016
BibTeX
@article{Yu2017,
author = {Yu, C and Peng, Y and Chongwu, R and Pengfei, R and Zheng, M and Lin, Z and Wenliang, Z and Changjie, J},
title = {Pharmacoeconomics of Three Hepatoprotectives for Liver Injury Induced by Antituberculosis Therapy},
journal = {West Indian Medical Journal},
year = {2017},
doi = {10.7727/wimj.2017.016}
}
EUVIMED